Your browser doesn't support javascript.
An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
Mishra, Ajay; Lal, Amos; Sahu, Kamal Kant; George, Anu Anna; Martin, Kevin; Sargent, Jennifer.
  • Mishra A; . ajay.mishra@stvincenthospital.com.
  • Lal A; Fellow in Critical Care and Pulmonary medicine. Lal.Amos@mayo.edu.
  • Sahu KK; Resident in Department of Internal Medicine. Kamalkant.Sahu@stvincenthospital.com.
  • George AA; Resident in Department of Internal Medicine. anugeorg@gmail.com.
  • Martin K; Consultant in Department of Critical Care and Pulmonary Medicine. Kevin.Martin@stvincenthospital.com.
  • Sargent J; Assistant Professor in Department of Internal Medicine. Jennifer.Sargent@stvincenthospital.com.
Acta Biomed ; 91(4): e2020155, 2020 11 10.
Article in English | MEDLINE | ID: covidwho-1059763
ABSTRACT
Coronavirus 19 disease (COVID-19) continues to be a pandemic with global implications.  Respiratory system involvement is the most common manifestation in symptomatic patients.  In this literature review, we describe the diagnosis, management, and implications of pulmonary hypertension (PH) among patients with COVID-19.  We defined pulmonary hypertension as increasing mean pulmonary artery pressure (mPAP) of ≥ 25 mm Hg at rest.  In our literature search, we identified 4 articles with details on pulmonary hypertension.  Among these, two reported various echocardiographic details for diagnosing pulmonary hypertension.  In 1 study evidence of pulmonary hypertension was noted in 13.4% of patientsPatients with severe COVID-19 were reported to have a higher proportion of pulmonary hypertension as compared to mild COVID-19 disease [22% vs 2%].  Elevated pulmonary artery systolic pressure was significant in predicting mortality.  COVID-19 patients with chronic obstructive pulmonary disease, congestive heart failure, myocardial injury, pulmonary embolism, and prior pulmonary hypertension were at a higher risk of worsening pulmonary hypertension.  Multiple mechanisms for developing pulmonary hypertension that have been postulated are i) concomitant worsening myocardial injury, ii) cytokine storm, endothelial injury, hypercoagulability attributing to development of venous thromboembolism, iii) and the presence of thrombotic microangiopathy.  Among patients with severe COVID-19 disease and pulmonary hypertension, complications including acute respiratory distress syndrome, acute myocardial injury, the requirement of intensive care unit admission, the requirement of mechanical ventilation, and mortality are higher.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension, Pulmonary Type of study: Diagnostic study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension, Pulmonary Type of study: Diagnostic study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article